YvonneCCollinsMD

Obstetrics & Gynecology • Oak Lawn, IL

Gynecologic Oncology

Assistant Professor, Obstetrics & Gynecology, University of Illinois College of Medicine

Join to view full profile

Dr. Collins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Collins' full profile

Already have an account?

Office
4440 W 95th St
Suite
Oak Lawn, IL 60453
Phone+1 708-684-5630

Fax+1 708-684-4949

Education & Training

University at BuffaloFellowship, Gynecologic Oncology, 2003
Cook County Health and Hospitals SystemResidency, Obstetrics and Gynecology, 1996 - 2000
University of Florida College of MedicineClass of 1996

Certifications & Licensure

MI State Medical License 2024 - 2027
IL State Medical License 1996 - 2026
CA State Medical License 2015 - 2021
NV State Medical License 2015 - 2021
FL State Medical License 2016 - 2020
MA State Medical License 2019 - 2020
NC State Medical License 2015 - 2020
VA State Medical License 2016 - 2020
NY State Medical License 2000 - 2005
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Join now to see all

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy Start of enrollment: 2010 Nov 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

165 citations
Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology
Yvonne C. Collins, Kevin Holcomb, Eloise Chapman-Davis, Dineo Khabele, John H. Farley
Gynecologic Oncology. 2014-05-01
249 citations
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
Loren K. Mell, J.D. Kochanski, John C. Roeske, Josh J. Haslam, Neil Mehta
International Journal of Radiation Oncology, Biology, Physics. 2005-10-01
9 citations
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Robert A. Burger, Wei Deng, Vicky Makker, Yvonne C. Collins, Heidi J. Gray
Gynecologic Oncology. 2018-09-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member